| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MAXCYTE, INC. | GENERAL COUNSEL | Common Stock | 64,219 | $204,171 | $3.18 | 18 Mar 2025 | Direct |
| MAXCYTE, INC. | GENERAL COUNSEL | Employee Stock Option (right to buy) | 92,500 | 14 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | 18 Mar 2025 | 1 | -$1,122 | 4 | GENERAL COUNSEL | 20 Mar 2025, 18:47 |
| MXCT | MAXCYTE, INC. | 14 Mar 2025 | 2 | $0 | 4 | GENERAL COUNSEL | 18 Mar 2025, 20:49 |
| MXCT | MAXCYTE, INC. | 13 Jan 2025 | 1 | -$20,272 | 4 | GENERAL COUNSEL | 14 Jan 2025, 16:03 |
| MXCT | MAXCYTE, INC. | 15 Mar 2024 | 2 | $0 | 4 | GENERAL COUNSEL | 19 Mar 2024, 18:20 |
| MXCT | MAXCYTE, INC. | 22 Feb 2024 | 0 | $0 | 3 | General Counsel | 04 Mar 2024, 17:39 |